Skip to main content

Table 5 Family characteristics and pathological characteristics of breast cancers of individuals with deleterious BRCA1 and BRCA2 mutations

From: Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer

 

Nucleotide change

AA change

Age of diagnosis of breast cancer

No. of breast/ovarian cancers in family

Mean age diagnosis (Breast cancer)

No. of cases (Breast cancer ≤ 50)

ER

PR

HER2

Grade

 

BRCA1

180 delA

STOP 22

55

2

43

1

-

-

-

2

IDC

 

185 delAG

STOP 39

33

1

33

1

-

-

-

3

IDC

 

185 insA

STOP 40

57

7

44

4

NA

NA

NA

NA

IDC

 

589 delCT

STOP 157

45

3

41

3

-

-

-

NA

IDC

 

1100 delAT

STOP 328

28

2

28

1

-

-

-

3

IDC

 

1173 G>T

E352X

45

3

45

1

-

-

-

2

IDC

 

1323 G>T

E402X

34

3

31

2

NA

NA

NA

NA

Sarcoma

 

3889 delAG

STOP1265

47

3

47

2

-

NA

+

NA

DCIS/IDC

 

4377 C>T

Q1420X

39

2

45

2

-

-

+/-

3

IDC

 

5370 C>T

R1751X

31

5

38

3

NA

NA

NA

NA

NA

 

IVS 3+1 G>T

 

46

2

47

2

-

NA

+

NA

IDC

 

IVS 3+2 delT

 

32

2

56

1

-

NA

-

2

IDC

 

IVS 4-1G>C

 

39

2

48

1

NA

NA

NA

NA

IDC

 

IVS5-12 A>G

 

33

1

33

1

-

-

-

3

IDC

BRCA2

490 delCT

STOP 99

39

2

56

1

-

-

-

2

IDC

 

490 delCT

STOP 99

51

4

45

3

+

+

-

NA

ILC

 

1184 insA

STOP 326

34

1

34

1

+

+

-

2

IDC

 

2001 del4

STOP 612

37

1

37

1

+

-

+

3

IDC

 

2699 del6

STOP 824

41

2

57

1

+

NA

NA

2

IDC

 

2864 delCT

STOP 879

40

1

40

1

-

NA

NA

3

IDC

 

4265 delCT

STOP 1350

55

4

44

3

+

+

-

2

IDC

 

6195 insA

STOP 2002

42

3

46

2

NA

NA

NA

NA

NA

 

6553 delGT

STOP 2109

59

3

49

1

+

NA

-

2

IDC

 

6901 delA

STOP 2228

35

1

35

1

NA

NA

NA

NA

IDC/DCIS

 

6943 G>T

E2239X

47

2

44

2

NA

NA

NA

NA

NA

 

9097 C>T

Q2957X

38

7

44

2

NA

NA

NA

NA

NA

 

9326 insA

STOP 3042

56

4

49

2

-

-

NA

NA

NA

 

IVS 17+1 G>A

 

36

2

46

1

-

-

-

3

IDC

  1. ER, oestrogen receptor; PR, progesterone receptor; AA, amino acid; DCIS, ductal carcinoma in situ; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma.